Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
COR Therapeutics, Inc., 256 East Grand Avenue, South San Francisco, California 94080, USA. dphillips@corr.com
The beta 3 integrin cytoplasmic tyrosine (ICY) motif of alpha IIb beta 3 becomes tyrosine phosphorylated during platelet aggregation, causing Shc and myosin to interact with the beta-integrin cytoplasmic domain. Platelets from mice lacking beta 3 ICY motif tyrosines formed defective aggregates and poorly retracted clots, establishing integrin tyrosine phosphorylation as a key mediator of beta 3-integrin signals.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on